on Lobe Sciences Ltd. (CVE:LOBE)
Lobe Sciences Ltd. Partners with Massive Intelligence for Investor Relations
On April 21, 2026, Lobe Sciences Ltd., a clinical stage biopharmaceutical company, announced its engagement of Massive Intelligence Pty Ltd. for investor relations and corporate communications. The initial three-month term began on April 15, 2026, with an option to extend for six months. Lobe Sciences will pay Massive Intelligence a monthly retainer totaling US$11,800 over three months. An additional US$31,500 is set for the optional extension.
Massive Intelligence will handle social media, email, and press communications without any securities exchange linked to their services. The firm remains independent from Lobe Sciences, having no current stakes or intentions to acquire stakes, beyond open market opportunities.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Lobe Sciences Ltd. news